HARMONY JPM 2025FINAL - Website.pdf

1、Copyright 2025 Harmony Biosciences.All rights reserved.43rd AnnualJP Morgan Healthcare ConferenceJ E F F R E Y M.D AY N O,M DJ a n u a r y 1 5,2 0 2 5|S a n F r a n c i s c oForward-Looking StatementsThis presentation includes forwardlooking statements within the meaning of the Private Securities Li

2、tigation Reform Act of 1995.All statements other than statements of historical facts contained in these materials or elsewhere,including statements regarding Harmony Biosciences Holdings,Inc.s(the“Company”)future financial position,preliminary financial results,business strategy and plans and object

3、ives of management for future operations,should be considered forward-looking statements.Forward-looking statements use words like“believes,”“plans,”“expects,”“intends,”“will,”“would,”“anticipates,”“estimates,”“may,”“could,”“might,”“continue,”“potential,”and similar words or expressions in discussio

4、ns of the Companys future operations,financial performance or the Companys strategies,but the absence of these words does not mean that a statement is not forward-looking.These statements are based on current expectations or objectives that are inherently uncertain.These forward-looking statements i

5、nvolve significant risks and uncertainties that could cause the actual results to differ materially from the expressed or implied forwarding-looking statements,including,but not limited to the risk factors discussed under the caption“Risk Factors”in the Companys Annual Report on Form 10-K filed with

6、 the U.S.Securities and Exchange Commission(the“SEC”)on February 22,2024 and its other filings with the SEC.While the Company may elect to update such forward-looking statements at some point in the future,it disclaims any obligation to do so,even if subsequent events cause its views to change.This